The American Alternative Care Policy Network (AACPN) this week launched its Psychedelic Research Initiative to support continued scientific research into emerging therapies that may help address some of America's most difficult mental health challenges. At the center of this effort are veterans. For many veterans, the invisible wounds of service can persist long after they return home. Post-traumatic stress, depression, anxiety, traumatic brain injury, substance-use disorders

AACPN applauds Connecticut’s enactment of Public Act 26-108, expanding the state’s psychedelic-assisted therapy pilot program and supporting continued clinical research involving MDMA and psilocybin therapies for veterans, first responders, trauma survivors, and individuals living with treatment-resistant mental health conditions.

AACPN welcomes the U.S. Department of Veterans Affairs’ launch of a clinical trial evaluating MDMA-assisted therapy for veterans living with PTSD and alcohol use disorder. The organization says rigorous scientific research is essential to understanding whether emerging therapies can safely and effectively support veterans and other trauma survivors facing complex behavioral health challenges.

The American Alternative Care Policy Network has launched a new initiative opposing upcoming federal restrictions on hemp-derived THC beverages and advocating for responsible, science-based regulation focused on consumer safety, harm reduction, trauma recovery, and evidence-based alternative care policy.

The TSA’s updated guidance on medical marijuana travel marks a significant step toward more practical and patient-centered federal cannabis policy. AACPN examines what the change means for veterans, medical cannabis patients, and the future of domestic travel reform.

The American Alternative Care Policy Network (AACPN) welcomes the unanimous passage of Louisiana legislation establishing a state-backed psychedelic-assisted therapy research initiative focused on mental health and substance-use disorders. The legislation reflects growing bipartisan recognition that treatment-resistant mental illness, PTSD, addiction, and veteran suicide require continued exploration of evidence-informed therapeutic innovation and expanded clinical research.

The American Alternative Care Policy Network (AACPN) today announced its launch, establishing a policy-driven platform to accelerate the integration of evidence-based alternative therapies into the U.S. healthcare system—where they can deliver measurable outcomes, expand access, and reduce long-term costs. AACPN enters a fragmented and often unserious policy environment with a clear mandate: impose rigor, elevate standards, and translate validated therapies into actionable le

The American Alternative Care Policy Network (AACPN) today issued the following statement in response to the Department of Justice’s decision to reclassify marijuana as a Schedule III substance under the Controlled Substances Act: “The Department of Justice’s decision to reschedule marijuana from Schedule I to Schedule III marks a meaningful, if overdue, shift in federal policy. By recognizing accepted medical use, this action begins to correct a long-standing misalignment be

The American Alternative Care Policy Network (AACPN) today issued the following statement in response to the White House executive order, “Breakthrough Mental Health Treatments — Delivering New Hope to Veterans,” which accelerates research and access to emerging therapies for serious mental illness: “The administration’s executive order represents a consequential shift in federal mental health policy—one that recognizes a hard truth: for millions of Americans suffering from..